CellaVision AB (publ) (CLVSF)
OTCMKTS
· Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025
CellaVision AB Revenue
CellaVision AB had revenue of 194.80M SEK in the quarter ending March 31, 2025, with 14.54% growth. This brings the company's revenue in the last twelve months to 747.94M, up 5.60% year-over-year. In the year 2024, CellaVision AB had annual revenue of 723.22M with 6.78% growth.
Revenue (ttm)
747.94M SEK
Revenue Growth
+5.60%
P/S Ratio
6.30
Revenue / Employee
3.42M SEK
Employees
219
Market Cap
469.60M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Northwest Biotherapeutics | 1.47M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
CellaVision AB News
- 4 months ago - CellaVision AB (CLVSF) Q4 2024 Earnings Call Highlights: Record APAC Sales and Strategic Growth ... - GuruFocus
- 4 months ago - Q4 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 8 months ago - Q3 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 4 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus